Jan Stern Reed - Jun 5, 2024 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Director
Signature
/s/ Donna Shiroma
Stock symbol
RCEL
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/6/2024, 07:21 PM
Previous filing
May 14, 2024
Next filing
Jul 19, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +9.2K +28.94% 41K Jun 5, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +3.94K $0.00 3.94K Jun 5, 2024 Common Stock 3.94K $9.51 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of RSUs, each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date.
F2 Includes unvested RSUs.